Back in September 2012, Professor Matthew Bennett, the PVC for Research, Enterprise and Internationalisation announced in a blog post that Bournemouth University was in the process of applying for membership of the Athena SWAN Charter, which was a positive and significant development for the University.
The Athena Swan charter recognises commitment to advancing women’s careers in science, technology, engineering, maths and medicine (STEMM) employment in higher education and is underpinned by three beliefs:
- The advancement of science, technology, engineering, maths and medicine is fundamental to quality of life across the globe
- It is vitally important that women are adequately represented in what has traditionally been, and is still, a male-dominated area
- Science cannot reach its full potential unless it can benefit from the talents of the whole population, and until women and men can benefit equally from the opportunities it affords
(information taken from http://www.athenaswan.org.uk/content/charter)
The University of Southampton, supported by EPSRC is hosting a Gender Equality Conference “Athena SWAN and Beyond” on the 20 March 2013. This is a FREE event and is a fantastic opportunity for those who are keen to get involved with Athena SWAN.
Event details are as below
To register for the event, please visit this webpage http://www.southampton.ac.uk/diversity/
You can also find out more about the event from here.
Athena SWAN – latest news and information
Athena SWAN – February Newsletter










Up2U: New BU academic publication
New BU midwifery paper
BU academic publishes in online newspaper in Nepal
Final day of the ESRC Festival of Social Science
Using Art to enhance Research
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease